304 related articles for article (PubMed ID: 36074052)
1. Real-world evidence for the long-term effect of allergen immunotherapy: Current status on database-derived European studies.
Vogelberg C; Klimek L; Brüggenjürgen B; Jutel M
Allergy; 2022 Dec; 77(12):3584-3592. PubMed ID: 36074052
[TBL] [Abstract][Full Text] [Related]
2. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
Wahn U; Bachert C; Heinrich J; Richter H; Zielen S
Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091
[TBL] [Abstract][Full Text] [Related]
3. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
Jutel M; Klimek L; Richter H; Brüggenjürgen B; Vogelberg C
Allergy; 2024 Apr; 79(4):1042-1051. PubMed ID: 38429981
[TBL] [Abstract][Full Text] [Related]
4. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
Devillier P; Wahn U; Zielen S; Heinrich J
Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
[TBL] [Abstract][Full Text] [Related]
5. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.
Vogelberg C; Brüggenjürgen B; Richter H; Jutel M
Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis.
Zielen S; Devillier P; Heinrich J; Richter H; Wahn U
Allergy; 2018 Jan; 73(1):165-177. PubMed ID: 28561266
[TBL] [Abstract][Full Text] [Related]
7. Allergen immunotherapy: what is the added value of real-world evidence from retrospective claims database studies?
Devillier P; Demoly P; Molimard M
Expert Rev Respir Med; 2020 May; 14(5):445-452. PubMed ID: 32131649
[No Abstract] [Full Text] [Related]
8. Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma.
Jutel M; Brüggenjürgen B; Richter H; Vogelberg C
Allergy; 2020 Aug; 75(8):2050-2058. PubMed ID: 32080856
[TBL] [Abstract][Full Text] [Related]
9. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
[TBL] [Abstract][Full Text] [Related]
10. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
Fritzsching B; Contoli M; Porsbjerg C; Buchs S; Larsen JR; Elliott L; Rodriguez MR; Freemantle N
Lancet Reg Health Eur; 2022 Feb; 13():100275. PubMed ID: 34901915
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
Vogelberg C; Klimek L; Kruppert S; Becker S
Clin Exp Allergy; 2024 Apr; 54(4):253-264. PubMed ID: 38146840
[TBL] [Abstract][Full Text] [Related]
12. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
Otolaryngol Head Neck Surg; 2024 Mar; 170(3):635-667. PubMed ID: 38408153
[TBL] [Abstract][Full Text] [Related]
13. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
Otolaryngol Head Neck Surg; 2024 Mar; 170 Suppl 1():S1-S42. PubMed ID: 38408152
[TBL] [Abstract][Full Text] [Related]
14. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
Hesse L; Petersen AH; Nawijn MC
Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of AIT in the elderly population.
Bożek A
Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):341-345. PubMed ID: 37357782
[TBL] [Abstract][Full Text] [Related]
16. Approach to Patients with Allergic Rhinitis: Testing and Treatment.
Cox L
Med Clin North Am; 2020 Jan; 104(1):77-94. PubMed ID: 31757239
[TBL] [Abstract][Full Text] [Related]
17. Does evidence support the use of cat allergen immunotherapy?
Dhami S; Agarwal A
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
[TBL] [Abstract][Full Text] [Related]
18. A review of allergen immunotherapy in asthma.
Caimmi D; Demoly P
Allergy Asthma Proc; 2022 Jul; 43(4):310-313. PubMed ID: 35818140
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.
Roxbury CR; Lin SY
Otolaryngol Clin North Am; 2017 Dec; 50(6):1111-1119. PubMed ID: 28964530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
